Similar to dysmetabolic humans, the DYS monkeys in the present study also showed marked hyperinsulinemia, a characterization of increased insulin resistance as defined by HOMA-IR or decreased insulin insensitivity as defined by QUICKI. This evidence concerns the gene INS and Insulin resistance.